AF
VOR icon

Amalgamated Financial’s Vor Biopharma VOR Stock Holding History

Amalgamated Financial’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$14K Buy
+119
New +$20.3K ﹤0.01% 2839

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Amalgamated Financial's VOR Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Vor Biopharma (VOR) in Q1 2022: 119 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #2839 among its holdings.

58 funds tracked by Wall St. Rank hold VOR as of Q1 2022.

  • Amalgamated Financial held 119 shares of Vor Biopharma worth $14K as of Q1 2022.
  • Vor Biopharma was a new Amalgamated Financial position in Q1 2022.
  • Vor Biopharma made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2839 holding.
  • 58 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.